Sanofi

About Sanofi

Sanofi is an R&D-driven, AI-powered biopharma company committed to improving people's lives through innovative science and creating compelling growth. Their mission is to chase the miracles of science for better health outcomes and sustainability.

Products & Services

Vaccines & Infectious Diseases:Includes vaccines for influenza, meningococcal meningitis, pertussis, and respiratory syncytial virus (RSV), emphasizing the importance of vaccines.

Medicines:Covers therapeutic areas like immunology, neurology, oncology, rare blood disorders, rare diseases, cardiovascular diseases, and diabetes.

Consumer Healthcare (Opella):Focuses on consumer healthcare products under the Opella brand.

Specialties

Immunology Neurology Oncology Rare Blood Disorders Rare Diseases Vaccines Artificial Intelligence in R&D Digital Health

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 2300000000 MR: - FA: 2.3 billion FAN: 2300000000	D: 2026-04-24 FD: 2026-04-24	7 investors
2	RT: Debt T: - FT: Debt	A: 3000000000 MR: - FA: USD 3 billion FAN: 3000000000	D: 2025-10-28 FD: 2025-10-28	7 investors
3	RT: Corporate Venture Capital Commitment T: - FT: Corporate Venture Capital Commitment	A: 625000000 MR: - FA: $625 million FAN: 625000000	D: 2025-09-24 FD: 2025-09-24	1 investors
4	RT: Debt T: - FT: Debt	A: 1620000000 MR: - FA: €1.5 billion FAN: 1620000000	D: 2025-06-17 FD: 2025-06-17	5 investors
5	RT: Debt T: - FT: Debt	A: 1500000000 MR: - FA: EUR 1.5 billion FAN: 1500000000	D: 2025-03-05 FD: 2025-03-05	5 investors
6	RT: Investment T: - FT: Investment	A: 1070000000 MR: - FA: approximately one billion euros FAN: 1070000000	D: 2024-12-02 FD: 2024-12-02	-
7	RT: Capital Commitment T: - FT: Capital Commitment	A: 750000000 MR: - FA: $750M FAN: 750000000	D: 2023-01-11 FD: 2023-01-11	1 investors
8	RT: Government Funding T: - FT: Government Funding	A: 2100000000 MR: - FA: 2.1 billion FAN: 2100000000	D: 2020-07-31 FD: 2020-07-31	1 investors

Debt Latest

2026-04-24

$2.3B

7 investors (Pro only)

Debt 2025-10-28

$3.0B

Corporate Venture Capital Commitment 2025-09-24

$625.0M

View 7 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

F

Frédéric Oudéa

Chairman of the Board of Directors

B

Belén Garijo

Director

C

Christophe Babule

Director

C

Clotilde Delbos

Independent director

H

Humberto De Sousa

Director representing employees (designated by the French Democratic Confederation of Labour – CFDT)

R

Rachel Duan

Independent director

View 25 more team members with Pro

Unlock Full Team Directory

Recent News

Sanofi Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised